Clinical Trial Update: Nesiritide Therapy to Preserve Function of the Left Ventricle After Myocardial Infarction [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating nesiritide therapy to preserve left ventricular function after acute myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Nesiritide (recombinant human B-type natriuretic peptide (rhBNP))

Snippet

Sponsor: Mayo Clinic | Conditions: Acute Myocardial Infarction | Phase 2 | Status: COMPLETED | Results posted: 2014-09-09